Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAWKY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,399
Award facts
- Contract value 100% obligated
- $23,398.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,398.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for XELJANZ XR 11 MG tablets (UU 30s) on September 12, 2025, with an ultimate completion date of September 15, 2025. The award carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order with place of performance in Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facility needs.
XELJANZ XR is an immunosuppressive medication used to treat rheumatoid arthritis and other autoimmune conditions. As a critical pharmaceutical supplier to Department of Defense healthcare sites nationwide, DMS Pharmaceutical Group leverages its established position within the federal supply chain to deliver specialized prescription medications and medical consumables to military medical facilities. The company's robust portfolio of federal contract awards demonstrates consistent capability in distributing branded and generic prescription drugs, biologics, and other pharmaceutical products essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FAWKY?
SPE2DB25FAWKY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FAWKY worth?
The government has obligated $23,399 on SPE2DB25FAWKY.
Is contract SPE2DB25FAWKY an order under another contract?
Yes. SPE2DB25FAWKY is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWKY competed?
The extent of competition for SPE2DB25FAWKY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award